Operating Expenses

Restructuring and Related Costs (Non-cash)

Thermo Fisher Scientific Restructuring and Related Costs (Non-cash) decreased by 21.1% to $15.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Metric ID: tmo_restructuring_non_cash_costs

Historical Data

12 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '26
Value$110.00M$7.00M-$4.00M$8.00M$24.00M$62.00M$96.00M$7.00M$4.00M$51.00M$19.00M$15.00M
QoQ Change-93.6%-157.1%+300.0%+200.0%+158.3%+54.8%-92.7%-42.9%>999%-62.7%-21.1%
YoY Change-92.7%+242.9%>999%>999%-70.8%-93.5%-46.9%+171.4%
Range-$4.00M$110.00M
CAGR-51.5%
Avg YoY Growth+357.5%
Median YoY Growth+62.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Thermo Fisher Scientific's restructuring and related costs (non-cash)?
Thermo Fisher Scientific (TMO) reported restructuring and related costs (non-cash) of $15.00M in Q1 2026.